The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Inactivating a Cellular Intrinsic Immune Defense Mediated by Daxx Is the Mechanism through Which the Human Cytomegalovirus pp71 Protein Stimulates Viral Immediate-Early Gene Expression
Open accessAbstract
Human cytomegalovirus (HCMV) masterfully evades adaptive and innate immune responses, allowing infection to be maintained and periodically reactivated for the life of the host. Here we show that cells also possess an intrinsic immune defense against HCMV that is disarmed by the virus. In HCMV-infected cells, the promyelocytic leukemia nuclear body (PML-NB) protein Daxx silences viral immediate-early gene expression through the action of a histone deacetylase. However, this antiviral tactic is efficiently neutralized by the viral pp71 protein, which is incorporated into virions, delivered to cells upon infection, and mediates the proteasomal degradation of Daxx. This work demonstrates the mechanism through which pp71 activates viral immediate-early gene expression in HCMV-infected cells. Furthermore, it provides insight into how a PML-NB protein institutes an intrinsic immune defense against a DNA virus and how HCMV pp71 inactivates this defense.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ishov, A. M., Sotnikov, A. G., Negorev, D., Vladimirova, O. V., Neff, N., Kamitani, T., Yeh, E. T. H., Strauss, J. F., & Maul, G. G. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.2.221 · Cited by 832
Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy
Mittereder, N., March, K. L., & Trapnell, B. C. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.7498-7509.1996 · Cited by 777
TRIM family proteins: retroviral restriction and antiviral defence
Nisole, S., Stoye, J. P., & Saïb, A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1248 · Cited by 761
Distinct roles for E2F proteins in cell growth control and apoptosis
DeGregori, J., Leone, G., Miron, A., Jakoi, L., & Nevins, J. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7245 · Cited by 703
Diagnosis and Management of Human Cytomegalovirus Infection in the Mother, Fetus, and Newborn Infant
Revello, M. G., & Gerna, G. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.4.680-715.2002 · Cited by 618
The transcriptional role of PML and the nuclear body
Zhong, S., Salomoni, P., & Pandolfi, P. P. (2000) · Nature Cell Biology · doi:10.1038/35010583 · Cited by 577
Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments
Gandhi, M. K., & Khanna, R. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01202-2 · Cited by 563
Human cytomegalovirus IE1 and IE2 proteins block apoptosis
Zhu, H., Shen, Y., & Shenk, T. (1995) · Journal of Virology · doi:10.1128/jvi.69.12.7960-7970.1995 · Cited by 468
Intrinsic immunity: a front-line defense against viral attack
Bieniasz, P. D. (2004) · Nature Immunology · doi:10.1038/ni1125 · Cited by 454
Compton, T., Nowlin, D. M., & Cooper, N. R. (1993) · Virology · doi:10.1006/viro.1993.1192 · Cited by 427
Everett, R. D., Freemont, P., Saitoh, H., Dasso, M., Orr, A., Kathoria, M., & Parkinson, J. (1998) · Journal of Virology · doi:10.1128/jvi.72.8.6581-6591.1998 · Cited by 402
Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus
Arnon, T. I., Achdout, H., Levi, O., Markel, G., Saleh, N., Katz, G., Gazit, R., Gonen-Gross, T., Hanna, J., Nahari, E., et al. (2005) · Nature Immunology · doi:10.1038/ni1190 · Cited by 397
Sequestration and Inhibition of Daxx-Mediated Transcriptional Repression by PML
Li, H., Leo, C., Zhu, J., Wu, X., O'Neil, J., Park, E.-J., & Chen, J. D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1784-1796.2000 · Cited by 364
Brooks, A. R., Harkins, R. N., Wang, P., Qian, H. S., Liu, P., & Rubanyi, G. M. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.516 · Cited by 362
Reeves, M. B., MacAry, P. A., Lehner, P. J., Sissons, J. G. P., & Sinclair, J. H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408994102 · Cited by 359
HSV-1 IE protein Vmw110 causes redistribution of PML.
Everett, R. D., & Maul, G. G. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06835.x · Cited by 351
Human Cytomegalovirus with IE-2 (UL122) Deleted Fails To Express Early Lytic Genes
Marchini, A., Liu, H., & Zhu, H. (2001) · Journal of Virology · doi:10.1128/jvi.75.4.1870-1878.2001 · Cited by 332
Chelbi-Alix, M. K., & de Thé, H. (1999) · Oncogene · doi:10.1038/sj.onc.1202366 · Cited by 332
Craig, K. L., & Tyers, M. (1999) · Progress in Biophysics and Molecular Biology · doi:10.1016/s0079-6107(99)00010-3 · Cited by 295
Role and fate of PML nuclear bodies in response to interferon and viral infections
Regad, T., & Chelbi-Alix, M. K. (2001) · Oncogene · doi:10.1038/sj.onc.1204854 · Cited by 281
Nuclear domain 10, the site of DNA virus transcription and replication
Maul, G. G. (1998) · BioEssays · doi:10.1002/(sici)1521-1878(199808)20:8<660::aid-bies9>3.0.co;2-m · Cited by 271
Hollenbach, A. D., McPherson, C. J., Mientjes, E. J., Iyengar, R., & Grosveld, G. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.16.3319 · Cited by 260
Control of cytomegalovirus lytic gene expression by histone acetylation
Murphy, J. C. (2002) · The EMBO Journal · doi:10.1093/emboj/21.5.1112 · Cited by 231
Greaves, R. F., & Mocarski, E. S. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.366-379.1998 · Cited by 229
Resistance to Virus Infection Conferred by the Interferon-Induced Promyelocytic Leukemia Protein
Chelbi-Alix, M. K., Quignon, F., Pelicano, L., Koken, M. H. M., & de Thé, H. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1043-1051.1998 · Cited by 229
The acute promyelocytic leukaemia-associated PML gene is induced by interferon.
Lavau, C., Marchio, A., Fagioli, M., Jansen, J. H., Falini, B., Lebon, P., Grosveld, F. G., Pandolfi, P. P., Pelicci, P. G., & Dejean, A. (1995) · PubMed · Cited by 228
Principles of Virology: Molecular Biology, Pathogenesis, and Control of Animal Viruses
Flint, S. J. (2003) · Medical Entomology and Zoology · Cited by 219
Liu, B., & Stinski, M. F. (1992) · Journal of Virology · doi:10.1128/jvi.66.7.4434-4444.1992 · Cited by 218
Retrovirus Restriction Factors
Goff, S. P. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.12.001 · Cited by 214
Hobbs, W. E., & DeLuca, N. A. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8245-8255.1999 · Cited by 206
The Pax3-FKHR oncoprotein is unresponsive to the Pax3-associated repressor hDaxx
Hollenbach, A. D. (1999) · The EMBO Journal · doi:10.1093/emboj/18.13.3702 · Cited by 203
Nevels, M., Paulus, C., & Shenk, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407933101 · Cited by 195
Kalejta, R. F., Bechtel, J. T., & Shenk, T. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.6.1885-1895.2003 · Cited by 193
Self-citationKalejta, R. F., & Shenk, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0538058100 · Cited by 191
Self-citationEAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes
Li, R., Pei, H., Watson, D. K., & Papas, T. S. (2000) · Oncogene · doi:10.1038/sj.onc.1203385 · Cited by 183
Regad, T. (2001) · The EMBO Journal · doi:10.1093/emboj/20.13.3495 · Cited by 177
Bresnahan, W. A., & Shenk, T. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14506 · Cited by 173
Hofmann, H., Sindre, H., & Stamminger, T. (2002) · Journal of Virology · doi:10.1128/jvi.76.11.5769-5783.2002 · Cited by 165
The Promyelocytic Leukemia Gene Product (PML) Forms Stable Complexes with the Retinoblastoma Protein
Alcalay, M., Tomassoni, L., Colombo, E., Stoldt, S., Grignani, F., Fagioli, M., Szekely, L., Helin, K., & Pelicci, P. G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.1084 · Cited by 161
IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis
Guldner, H. H., Szostecki, C., Grötzinger, T., & Will, H. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.12.4067 · Cited by 156
Mocarski, E. S. (2004) · Cellular Microbiology · doi:10.1111/j.1462-5822.2004.00425.x · Cited by 144
Cinatl, J. J., Vogel, J., Kotchetkov, R., & Doerr, H. W. (2003) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2003.07.005 · Cited by 143
Maul, G. G., Yu, E., Ishov, A. M., & Epstein, A. L. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240590410 · Cited by 143
RNAi reveals anti-apoptotic and transcriptionally repressive activities of DAXX
Michaelson, J. S., & Leder, P. (2002) · Journal of Cell Science · doi:10.1242/jcs.00234 · Cited by 140
Daxx Silencing Sensitizes Cells to Multiple Apoptotic Pathways
Chen, L., & Chen, J. D. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.20.7108-7121.2003 · Cited by 140
The Interaction of Pax5 (BSAP) with Daxx Can Result in Transcriptional Activation in B Cells
Emelyanov, A. V., Kovac, C. R., Sepúlveda, M. A., & Birshtein, B. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111763200 · Cited by 125
Nowak, B., Sullivan, C. A., Sarnow, P., Thomas, R., Bricout, F., Nicolas, J., Fleckenstein, B., & Levine, A. J. (1984) · Virology · doi:10.1016/0042-6822(84)90039-4 · Cited by 114
Daxx Mediates the Small Ubiquitin-like Modifier-dependent Transcriptional Repression of Smad4
Chang, C., Lin, D.-Y., Fang, H.-I., Chen, R., & Shih, H.-M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409161200 · Cited by 114
Cantrell, S. R., & Bresnahan, W. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7792-7802.2005 · Cited by 114
Meier, J. L. (2001) · Journal of Virology · doi:10.1128/jvi.75.4.1581-1593.2001 · Cited by 106
Improvements in Gene Therapy: Averting the Immune Response to Adenoviral Vectors
Ritter, T., Lehmann, M., & Volk, H. (2002) · BioDrugs · doi:10.2165/00063030-200216010-00001 · Cited by 105
Poon, A. P. W., Liang, Y., & Roizman, B. (2003) · Journal of Virology · doi:10.1128/jvi.77.23.12671-12678.2003 · Cited by 90
Everett, R. D., O’Hare, P., O’Rourke, D., Barlow, P. N., & Orr, A. (1995) · Journal of Virology · doi:10.1128/jvi.69.11.7339-7344.1995 · Cited by 86
Greger, J., Katz, R. A., Ishov, A. M., Maul, G. G., & Skalka, A. M. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.4610-4618.2005 · Cited by 68
PML interacts with Myc, and Myc target gene expression is altered in PML-null fibroblasts
Cairo, S., Falco, F. D., Pizzo, M., Salomoni, P., Pandolfi, P. P., & Meroni, G. (2005) · Oncogene · doi:10.1038/sj.onc.1208338 · Cited by 49
Preston, C. M., & Nicholl, M. J. (2004) · Journal of Virology · doi:10.1128/jvi.79.1.525-535.2005 · Cited by 43
Kronschnabl, M., & Stamminger, T. (2003) · Journal of General Virology · doi:10.1099/vir.0.18703-0 · Cited by 26
Cited by
Randall, R. E., & Goodbourn, S. (2008) · Journal of General Virology · doi:10.1099/vir.0.83391-0 · Cited by 1,571
Chromatin control of herpes simplex virus lytic and latent infection
Knipe, D. M., & Cliffe, A. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1794 · Cited by 444
PML and PML nuclear bodies: Implications in antiviral defence
Everett, R. D., & Chelbi-Alix, M. K. (2007) · Biochimie · doi:10.1016/j.biochi.2007.01.004 · Cited by 439
Manifestations of Human Cytomegalovirus Infection: Proposed Mechanisms of Acute and Chronic Disease
Britt, W. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-77349-8_23 · Cited by 345
Everett, R. D., Rechter, S., Papior, P., Tavalai, N., Stamminger, T., & Orr, A. (2006) · Journal of Virology · doi:10.1128/jvi.00734-06 · Cited by 327
Metadata
- Authors
- Saffert, R. T., & Kalejta, R. F.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2006-04-15
- Volume
- 80
- Issue
- 8
- Pages
- 3863-3871
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2102621085
- Cited by
- 284
- References
- 57
- FWCI
- 13.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.